Causaly Launches Agentic AI Platform to Transform Life Sciences R&D

LONDON, Sept. 16, 2025 — Causaly has unveiled Causaly Agentic Research, a breakthrough agentic AI platform purpose-built for life sciences research and development. The new solution introduces specialized multi AI agents that automate complex research workflows, integrate internal and external biomedical data, and deliver transparent, evidence-backed insights to accelerate drug discovery and development.

With a conversational interface and domain-specific agents, Causaly Agentic Research empowers scientists to scale R&D operations, test hypotheses, and uncover novel insights all within a single, intelligent environment that maintains scientific rigor and traceability.

Read the full announcement on PR Newswire →

‍